The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
Q32 Bio Inc (NASDAQ: QTTB) closed the day trading at $3.46 up 4.22% from the previous closing price of $3.32. In other words, the price has increased by $4.22 from its previous closing price. On the day, 0.8 million shares were traded. QTTB stock price reached its highest trading level at $3.64 during the session, while it also had its lowest trading level at $3.15.
Ratios:
For a better understanding of QTTB, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.57 and its Current Ratio is at 4.57.
Upgrades & Downgrades
In the most recent recommendation for the company, Piper Sandler on February 11, 2025, Downgraded its rating to Neutral and sets its target price to $4 from $20 previously.
On February 11, 2025, BMO Capital Markets Downgraded its rating to Market Perform which previously was Outperform and also lowered its target price recommendation from $22 to $3.
Wells Fargo Downgraded its Overweight to Equal Weight on December 11, 2024, whereas the target price for the stock was revised from $95 to $16.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 02 ’25 when Morrison Jodie Pope sold 22,506 shares for $3.46 per share. The transaction valued at 77,871 led to the insider holds 99,000 shares of the business.
Kalowski Lee sold 9,072 shares of QTTB for $31,395 on Dec 02 ’25. The CFO and President now owns 39,938 shares after completing the transaction at $3.46 per share. On Dec 02 ’25, another insider, JODIE MORRISON, who serves as the Officer of the company, bought 22,506 shares for $3.46 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, QTTB now has a Market Capitalization of 42573060 and an Enterprise Value of 8836449.
Stock Price History:
The Beta on a monthly basis for QTTB is 0.16, which has changed by -0.8639902 over the last 52 weeks, in comparison to a change of 0.13844287 over the same period for the S&P500. Over the past 52 weeks, QTTB has reached a high of $28.06, while it has fallen to a 52-week low of $1.35. The 50-Day Moving Average of the stock is 28.15%, while the 200-Day Moving Average is calculated to be 66.95%.
Shares Statistics:
Over the past 3-months, QTTB traded about 3.00M shares per day on average, while over the past 10 days, QTTB traded about 17840500 shares per day. A total of 12.30M shares are outstanding, with a floating share count of 4.59M. Insiders hold about 62.99% of the company’s shares, while institutions hold 10.86% stake in the company. Shares short for QTTB as of 1763078400 were 277802 with a Short Ratio of 0.09, compared to 1760486400 on 464505. Therefore, it implies a Short% of Shares Outstanding of 277802 and a Short% of Float of 7.85.
Earnings Estimates
A detailed examination of Q32 Bio Inc (QTTB) is currently in progress, with 2.0 analysts providing valuable insights into its market dynamics.
Analysts are recommending an EPS of between -$2.16 and -$3.35 for the fiscal current year, implying an average EPS of -$2.76. EPS for the following year is -$2.6, with 2.0 analysts recommending between -$1.13 and -$4.07.
